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Relationships between baseline rotational knee loading and changes in cartilage volume over 1 year
Annual cartilage volume loss Univariate analysis Multivariate analysisy
Regression coefﬁcient (95% CI) P Regression coefﬁcient (95% CI) P
Medial tibial cartilage volume (mm3)
Peak KRM (Nm/BW*HT%) -0.21 (-0.49 to 0.07) 0.145 -0.20 (-0.48 to 0.09) 0.178
KRM angular impulse (Nm.s/BW*HT%) -0.92 (-1.8 to -0.03) 0.042 -1.05 (-1.98 to -0.12) 0.027
Lateral tibial cartilage volume (mm3)
Peak KRM (Nm/BW*HT%) -0.99 (-1.83 to -0.17) 0.019 -1.07 (-1.89 to -0.24) 0.012
KRM angular impulse (Nm.s/BW*HT%) -2.53 (-5.18 to 0.11) 0.060 -3.18 (-6.11 to -0.76) 0.012
Total tibial cartilage volume (mm3)
Peak KRM (Nm/BW*HT%) -0.34 (-0.59 to -0.08) 0.010 -0.35 (-0.60 to -0.09) 0.008
KRM angular impulse (Nm.s/BW*HT%) -1.02 (-1.83 to -0.21) 0.014 -1.29 (-2.11 to -0.47) 0.002
y Adjusted for age, gender, body mass index, static knee alignment, baseline value, MRI machine and treatment group
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MALDI IMAGING MASS SPECTROMETRY REVEALS A DIFFERENT
PROTEIN DISTRIBUTION IN HUMAN CONTROL AND OA CARTILAGE
B. Cillero-Pastor 1, G. Eijkel 1, A. Kiss 1, F. Blanco 2, R. Heeren 1. 1AMOLF-
FOM Inst., Amsterdam, Netherlands; 2 INIBIC-CHUAC, A Coruña, Spain
Purpose: The knowledge of the distribution and the modulation of
proteins in the osteoarthritis (OA) is necessary to understand the
changes in the cartilage during the development of the disease. Matrix
assisted laser desorption ionization (MALDI) imaging mass spectrom-
etry (IMS) allows us to study the spatial distribution of different
proteins with a high resolution in a section of tissue. In this study, we
have studied the location and the abundance of OA-related proteins in
different areas of normal and osteoarthritic (OA) human cartilage by
MALDI IMS.
Methods: Human control and OA cartilage samples were cut by tripli-
cate obtaining 10 mm thick sections and being deposited in indium tin
oxide (ITO) high conductivity slides. Samples were washed and diges-
ted. Spots of trypsin were deposited by a high-accuracy position auto-
matic chemical inkjet printer. Alpha-Cyano-4-hydroxycinnamic acid
matrix (HCCA) was deposited by a vibrational sprayer system. Synapt
HDMSMALDI-Q-TOF was used to perform the imaging-MS experiments
with a spatial resolution of 150 mm. To perform the peptide identiﬁca-
tion, Mascot algorithm was employed after proﬁling MS/MS and
imaging-MS/MS experiments. Biomap software was used to study the
location and to quantify the intensity of the different peptides. Inmu-
nohistochemistry analyses were used to validate the results. Hema-
toxylin-eosin staining complemented the spatial information. Principal
Component Analysis (PCA) and Discriminant Analysis (DA) were used
for data interpretation.
Results: We have previously described a higher presence of Fibro-
nectin, Cartilage intermediate layer protein 1 (CILP1), Cartilage oligo-
meric matrix protein (COMP) and other possible biomarkers in the
human OA cartilage by MALDI-IMS. Using Biomap software we have
quantiﬁed the differences in OA vs. control samples, observing that the
abundance of the peptides related to Fibronectin (m/z 1349.7, m/z
1401.7, m/z 1593.7, m/z 1431.7, m/z 1323.7) and COMP (m/z 1613.8, m/z
2256.1) increased in OA respect to normal samples but also with
a clear difference between the deep and the superﬁcial areas (table)
[Deep OA vs. Deep Normal, P*<0.05; Superﬁcial OA vs. Superﬁcial
Normal, P&<0.05]. We also plotted the number of pixels vs. the
average intensity observed for two of these OA-related peaks (m/z
1349.7 and m/z 2373.7). The maximum intensity reached in the OA
samples for the Fibronectin related peptide 1349.7, and for the hypo-
thetical biomarker m/z 2373.7, was higher than the maximum inten-
sity observed in the control cartilages (0.3 and 0.25 vs. 0.08 and 0.04
respectively). Moreover, in the OA spectra we could distinguish two
different distributions: the ﬁrst one with a low intensity (but higher
than the intensities of the control distribution) and the second one
with a high average intensity, showing the heterogeneity of the protein
distribution that we can ﬁnd in the human OA cartilage. We also
validated the results of Fibronectin distribution by inmunohis-
tochemistry, observing again a higher presence in the deep area of OA
than in normal samples (0.20.0% normal vs. 0.710.32% OA; n¼3,
P*<0.05).
Conclusions:We have observed a high presence of OA-related proteins
and possible candidates in the deep area of the cartilage by MALDI-IMS.
This fact could help us to understand the role of the deep area in the
joint remodelling that characterizes the OA pathology.Quantitation of OA speciﬁc peptides
m/z Superﬁcial Normal Deep Normal Superﬁcial OA Deep OA1349.7 0.160.12 0.190.12 1.580.77& 2.451.37*
1401.7 0.160.10 0.170.10 0.450.11 0.640.13*
1593.7 0.090.04 0.110.05 0.630.34& 1.140.75*
1431.7 0.250.12 0.290.15 0.660.22 0.990.33
1323.7 0.100.07 0.130.08 0.790.56 1.871.49*
1613.8 0.200.15 0.230.18 0.550.21 0.870.30
2256.1 0.110.06 0.120.06 0.200.07 0.290.11
2377.3 0.050.03 0.050.03 0.460.34 0.710.54*17
NON-INVASIVE SODIUM MR IMAGING AND QUANTIFICATION OF IN-
VIVO ARTICULAR CARTILAGE AT 1.5 TESLA
A.M. Hani, D. Kumar, A. Malik, N. Walter. Universiti Teknologi Petronas,
Tronoh, Malaysia
Purpose: Osteoarthritis (OA) can be characterised by the gradual loss of
articular cartilage (AC). At the very early stages, the loss of proteoglycan
from the extracellular matrix of articular cartilage has been associated
with the onset of OA. Sodium magnetic resonance imaging has been
shown to be sensitive in detecting small changes in proteoglycan
content of articular cartilage at high ﬁeld (>4Tesla) MR systems. This
work aims to investigate the possibility of imaging and quantiﬁcation of
local sodium content of articular cartilage using sodium MRI at 1.5Tesla
clinical MR system.
Methods: A dual tuned knee coil equipped with proton (1H) and sodium
(23Na) channels tuned at 63.6 MHz and 16.8 MHz respectively is used to
scan phantoms and human subjects. All the scans were performed using
a 1.5T clinical MR system (Siemens Medical Solutions, Erlangen,
Germany). Prior to human subjects, scanning was performed on
phantoms. Sodium imaging of knee and phantoms were performed
using 3D Gradient Echo sequence (TR/TE ¼ 11.4/4.0 ms, ﬂip angle ¼ 62,
isotropic resolution ¼ 2.81 x 2.81 x 8 mm3, and total acquisition
time w30 min). For the absolute measurement of sodium content in
AC, a calibration marker (plastic tube with 300mmol/kg sodium
concentration) was placed next to the human knee as sodium reference.
In addition to sodium imaging, proton imaging was also performed
using MEDIC 3D sequence (TR/TE ¼ 37/20 ms, ﬂip angle ¼ 8, isotropic
resolution ¼ 0.47 x 0.51 x 1.5mm3, and total acquisition timew5 min).
Sodium concentration was determined in the AC ([Na]AC) region of
23Na MRI images as ratio of the mean 23Na signal intensities (SNa) in
cartilage region to the sodium signal from reference marker (SNa,ref) of
300mmol/L sodium concentration ([Na]ref) using the Equation 1:
½NaAC[ ðSNa=SNa; refÞ  ½Naref (1)
Results: High resolution proton images of phantom and human knee
were acquired as shown in Figure 1a and 1b respectively, while the
corresponding sodium images are shown in Figure 1c and 1d. The mean
sodium signal intensities calculated from the sodium reference (see
arrow in Figure 1e) and articular cartilage (Figure 1f) in sodium MRI
image are 199 and 168 for 22 and 81 pixels respectively, representing
homogeneous and intense sodium signal in both reference and AC . The
estimated sodium concentration in AC region from sodium image is
253mmol/L, which correspond to values reported for the normal AC.
